Status of Polymer Fused Deposition Modeling (FDM)-Based Three-Dimensional Printing (3DP) in the Pharmaceutical Industry
Author | Iqbal, Heba |
Author | Fernandes, Queenie |
Author | Idoudi, Sourour |
Author | Basineni, Renuka |
Author | Billa, Nashiru |
Available date | 2024-04-24T09:53:23Z |
Publication Date | 2024 |
Publication Name | Polymers |
Resource | Scopus |
ISSN | 20734360 |
Abstract | Additive manufacturing (AM) or 3D printing (3DP) is arguably a versatile and more efficient way for the production of solid dosage forms such as tablets. Of the various 3DP technologies currently available, fused deposition modeling (FDM) includes unique characteristics that offer a range of options in the production of various types of tablets. For example, amorphous solid dispersions (ASDs), enteric-coated tablets or poly pills can be produced using an appropriate drug/polymer combination during FDM 3DP. The technology offers the possibility of evolving personalized medicines into cost-effective production schemes at pharmacies and hospital dispensaries. In this review, we highlight key FDM features that may be exploited for the production of tablets and improvement of therapy, with emphasis on gastrointestinal delivery. We also highlight current constraints that must be surmounted to visualize the deployment of this technology in the pharmaceutical and healthcare industries. |
Sponsor | Open access publication fee was funded by Qatar National Library. |
Language | en |
Publisher | Multidisciplinary Digital Publishing Institute (MDPI) |
Subject | amorphous solid dispersion fused deposition modeling pharmaceutical polymer solubility three-dimensional printing |
Type | Article Review |
Issue Number | 3 |
Volume Number | 16 |
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [1509 items ]
-
Pharmacy Research [1314 items ]